Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

[Multiple sclerosis, neuromyelitis optica and spasticity: control of specific symptoms and quality of life].
NMDA receptor antibodies associated with distinct white matter syndromes.
Pathological Involvement of Astrocyte-Derived Lipocalin-2 in the Demyelinating Optic Neuritis.
Systemic Injection of Neural Stem/Progenitor Cells in Mice with Chronic EAE.
Seizure characteristics in multiple sclerosis patients.
Impact on health-related quality of life in multiple sclerosis patients due to a managed care program in Colombia.
Breastfeeding and Disease-Modifying Therapy for Multiple Sclerosis-Reply.
ATON: Results from a Phase II randomized trial of the B-cell-targeting agent atacicept in patients with optic neuritis.
A Case of Anti-aquaporin-4 Antibody-Seronegative NMO Spectrum Disorder with Baló Concentric Lesions.
Brainstem manifestations in neuromyelitis optica: a multicenter study of 258 patients.
A single session of 1 mA anodal tDCS-supported motor training does not improve motor performance in patients with multiple sclerosis.
Naturally Occurring Antibodies as Therapeutics for Neurologic Disease : Can Human Monoclonal IgMs Replace the Limited Resource IVIG?
Antagonistic effects of IL-17 and D-resolvins on endothelial Del-1 expression through a GSK-3β-C/EBPβ pathway.
S1P signaling: new therapies and opportunities.
Promotion of remyelination by adipose mesenchymal stem cell transplantation in a cuprizone model of multiple sclerosis.
Novartis MS pill heads stream of SMC approvals
Mean Contact Quotient Using Electroglottography in Patients With Multiple Sclerosis.
Current and Future Therapies Targeting the Immune System in Multiple Sclerosis.
Chronic primary central nervous system histoplasmosis in a healthy child with intermittent neurological manifestations.
Sex-specific environmental influences affecting MS development.
Evidence for the efficacy and effectiveness of THC-CBD oromucosal spray in symptom management of patients with spasticity due to multiple sclerosis.
Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis.
Temporal Hierarchical Adaptive Texture CRF for Automatic Detection of Gadolinium-Enhancing Multiple Sclerosis Lesions in Brain MRI.
Tetrahydrocannabinol for tremor in multiple sclerosis.
Mobility, Walking And Physical Activity In Persons With Multiple Sclerosis.

Pages